Human immunodeficiency virus infection abolishes CD4-dependent activation of ZAP-70 by inhibition of p56lck

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue 3, 1997, Pages 204-212

  Guntermann, Christine ^a   Dye, Julian ^b   Nye, Keith E ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Coreceptor signalling; Immunosuppression; Lymphocyte activation; Protein phosphorylation

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; PHOSPHOTRANSFERASE; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; TYROSINE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; VIRUS PATHOGENESIS;

ANTIGENS, CD3; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DOWN-REGULATION; HIV-1; HUMANS; IMMUNOLOGIC CAPPING; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; ZAP-70 PROTEIN-TYROSINE KINASE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030952901     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199703010-00002     Document Type: Article

References (40)

1. Evans LA, Levy JA. The heterogeneity and pathogenicity of HIV-1. In: Morrow WJW, Haigwood NL, eds. HIV molecular organization, pathogenicity and treatment. Amsterdam: Elsevier, 1993:137-52.
2. Klasse PJ, Moore JP, Jameson BA. The interplay of the HIV-1 envelope complex, gp120 and gp41, with CD4. In: Morrow WJW, Haigwood NL, eds. HIV molecular organization, pathogenicity and treatment. Amsterdam: Elsevier, 1993:241-65.
3. Lasky L, Nakamura G, Smith DH, et al. Delineation of a region of the human immunodeficiency virus type 1 gp 120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987;50:975-85.
4. Cammarota G, Schierle A, Takacs B, et al. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature 1992;356:799-801.
5. Doyle C, Strominger JL. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 188;330:256-8.
6. Eichmann K, Jonsson JI, Falk I, Emmrich F. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4. Eur J Immunol 1987;17:643-50.
7. Rudd CE, Trevillyan JM, Dasgupta JD, Wong LL, Schlossmann SF. The CD4 receptor is complexed in detergent lysates to a protein kinase (pp58) from human T lymphocytes. Proc Natl Acad Sci USA 1988;85:5190-4.
8. lck. Cell 1988;55:301-8.
9. lck. Nature 1989;338:257-9.
10. Koretzky GA, Picus J, Schultz T, Weiss A. Tyrosine phosphatase CD45 is essential for coupling T cell antigen receptor-and CD2-mediated activation of a protein-tyrosine kinase and interleukin 2 production. Proc Natl Acad Sci USA 1991; 88:2037-41.
11. lck) that phosphorylates the CD3 complex. Proc Natl Acad Sci USA 1989;86:3277-81.
12. lck, Science 1992;255:853-5.
13. Weber JR, Bell GM, Han MY, Pawson T, Imboden JB. Association of the tyrosine kinase LCK with phospholipase C-γl after stimulation of the T cell antigen receptor. J Exp Med 1992;176:373-9.
14. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994;76:263-74.
15. lck with CD4 in antigen-specific signal transduction in T cells. Cell 1991;64:511-20.
16. Strauss DB, Weiss A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992;70:585-93.
17. Horak ID, Popovic M, Horak EM, et al. No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120. Nature 1990;348: 557-60.
18. lck with CD4 in human T lymphocytes. J Biol Chem 1991;266:11176-83.
19. lck activation and TCR desensitization independent of TCR tyrosine phosphorylation. J Immunol 1994;153:2905-17.
20. lck in human CD4 T lymphocytes. Eur J Immunol 1993;23:600-7.
21. Hofmann B, Nishaman P, Baldwin RL, Insixiengmay P, Nel A, Fahey JL. HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism. J Immunol 1990;145:3699-705.
22. Kornfeld H, Cruikshank WW, Pyle SW, Berman JS, Center DM. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 1988;335:445-8.
23. Cefai D, Debré P, Kaczorek M, Idziorek T, Autran B, Bismuth G. Human immunodeficiency virus-1 glycoprotein gp120 and gp160 specifically inhibit the CD3/Tcell-antigen receptor phosphoinositide transduction pathway. J Clin Invest 1990;86: 2117-24.
24. Moore JP, Mc Keating JA, Weiss RA, Sattentau QJ. Dissoclation of gp120 from HIV-1 virions induced by soluble CD4. Science 1990;250:1139-42.
25. Kanner SB, Reynolds AB, Parsons JT. Immunoaffinity purification of tyrosine-phosphorylated cellular proteins. J Immunol Methods 1989;120:115-24.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
27. Fauci AS, Schnittman SM, Poli G, Koenig S, Pamaleo G. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991;114:678-93.
28. Diamond DC, Sleckman BP, Gregory T, Lasky LA, Greenstein JL, Burakoff SJ. Inhibition of CD4+ T cell function by the HIV envelope protein gp120. J Immunol 1988;141:371-7.
29. Cohen DI, Tani Y, Tian H, Boone E, Samelson LE, Lane HC. Participation of tyrosine phosphorylation in the cytopathic effect of human-immunodeficiency virus-1. Science 1992; 256:542-5.
30. Nye KE, Pinching AJ. HIV infection of H9 lymphoblastoid cells chronically activates the inositol polyphosphate pathway. AIDS 1990;4:41-5.
31. Ng TTC, Guntermann C, Nye KE, Parkin JM, Anderson J, Norman JE, Morrow WJW. Adhesion co-receptor expression and intracellular signalling in HIV disease: implications for immunotherapy. AIDS 1995;9:337-43.
32. Garcia JV, Miller AD. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 1991; 350:508-11.
33. Banda NK, Bernier J, Kurahara DK, et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992;176:1099-506.
34. lck dissociation. J Immunol 1995;154:2996-3005.
35. Crabtree GR, Clipstone NA. Signal transmission between the plasma membrane and the nucleus of T lymphocytes. Annu Rev Biochem 1994;63:1045-83.
36. Chan AC, Irving BA, Fraser JD, Weiss A. The ζ chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc Natl Acad Sci USA 1991;88:9166-70.
37. Greenway A, Azad A, McPhee D. Human immunodeficiency virus type 1 nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J Virol 1995;69:1842-50.
38. Garcia JV, Alfano J, Miller AD. The negative effect of human immunodeficiency virus type 1 nef on cell surface expression is not species specific and requires the cytoplasmic domain of CD4. J Virol 1993;67:1511-6.
39. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 1994;76:853-64.
40. Chan A, Desai DM, Weiss A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol 1994;12: 555-592.